BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27230481)

  • 1. Visual function in patients with idiopathic macular telangiectasia type 1.
    Sugiura Y; Okamoto F; Okamoto Y; Hiraoka T; Oshika T
    Acta Ophthalmol; 2016 Nov; 94(7):e672-e673. PubMed ID: 27230481
    [No Abstract]   [Full Text] [Related]  

  • 2. Optical coherence tomographic angiography in type 1 idiopathic macular telangiectasia.
    Pappuru RR; Peguda HK; Dave VP
    Clin Exp Optom; 2018 Jan; 101(1):143-144. PubMed ID: 28295586
    [No Abstract]   [Full Text] [Related]  

  • 3. Type 2 idiopathic macular telangiectasia.
    Shukla D; Gupta SR; Neelakantan N; Tiwari S; Gupta S; Patwardhan AR; Soubhya TB
    Retina; 2012 Feb; 32(2):265-74. PubMed ID: 21968508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cone pathologic changes in idiopathic macular telangiectasia types 1 and 2 using adaptive optics scanning laser ophthalmoscopy.
    Ooto S; Hangai M; Takayama K; Ueda-Arakawa N; Tsujikawa A; Yamashiro K; Oishi A; Hanebuchi M; Yoshimura N
    Am J Ophthalmol; 2013 Jun; 155(6):1045-1057.e4. PubMed ID: 23465268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VERY EARLY DISEASE MANIFESTATIONS OF MACULAR TELANGIECTASIA TYPE 2.
    Charbel Issa P; Heeren TF; Kupitz EH; Holz FG; Berendschot TT
    Retina; 2016 Mar; 36(3):524-34. PubMed ID: 26618805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo evaluation of photoreceptor mosaic in type 2 idiopathic macular telangiectasia using adaptive optics.
    Massamba N; Querques G; Lamory B; Querques L; Souied E; Soubrane G
    Acta Ophthalmol; 2011 Nov; 89(7):e601-3. PubMed ID: 20809908
    [No Abstract]   [Full Text] [Related]  

  • 7. Retinal structural alterations and macular sensitivity in idiopathic macular telangiectasia type 1.
    Takayama K; Ooto S; Tamura H; Yamashiro K; Otani A; Tsujikawa A; Yoshimura N
    Retina; 2012 Oct; 32(9):1973-80. PubMed ID: 22487581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Documentation of Spontaneous Macular Hole Closure in Macular Telangiectasia Type 2 Using Multimodal Imaging.
    Balaratnasingam C; Dansingani K; Dhrami-Gavazi E; Yu S; Freund KB; Yannuzzi LA
    Ophthalmic Surg Lasers Imaging Retina; 2015 Sep; 46(8):883-6. PubMed ID: 26431306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal bevacizumab for treatment of proliferative and nonproliferative type 2 idiopathic macular telangiectasia.
    Roller AB; Folk JC; Patel NM; Boldt HC; Russell SR; Abramoff MD; Mahajan VB
    Retina; 2011 Oct; 31(9):1848-55. PubMed ID: 21610563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First symptoms and their age of onset in macular telangiectasia type 2.
    Heeren TF; Holz FG; Charbel Issa P
    Retina; 2014 May; 34(5):916-9. PubMed ID: 24351446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occlusive idiopathic juxtafoveolar retinal telangiectasis type 4.
    Matonti F; Chazalon E; Hoffart L; Roux L; Denis D
    Can J Ophthalmol; 2013 Jun; 48(3):e45-7. PubMed ID: 23769792
    [No Abstract]   [Full Text] [Related]  

  • 12. Progressive changes from idiopathic macular telangiectasia seen with spectral domain optical coherence tomography.
    Fallano KA; Ibrahim M; Nguyen QD; Do DV
    Can J Ophthalmol; 2010 Dec; 45(6):649-50. PubMed ID: 20648067
    [No Abstract]   [Full Text] [Related]  

  • 13. Multimodality imaging in macular telangiectasia 2: A clue to its pathogenesis.
    Wu L
    Indian J Ophthalmol; 2015 May; 63(5):394-8. PubMed ID: 26139799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monthly ranibizumab for nonproliferative macular telangiectasia type 2: a 12-month prospective study.
    Charbel Issa P; Finger RP; Kruse K; Baumüller S; Scholl HP; Holz FG
    Am J Ophthalmol; 2011 May; 151(5):876-886.e1. PubMed ID: 21334595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and therapeutic challenges.
    Querques G; Lattanzio R; Querques L; Bandello F; Freund KB
    Retina; 2013 Jan; 33(1):240-3. PubMed ID: 23095768
    [No Abstract]   [Full Text] [Related]  

  • 16. High-resolution photoreceptor imaging in idiopathic macular telangiectasia type 2 using adaptive optics scanning laser ophthalmoscopy.
    Ooto S; Hangai M; Takayama K; Arakawa N; Tsujikawa A; Koizumi H; Oshima S; Yoshimura N
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5541-50. PubMed ID: 21642620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of macular function with retinal thickness in nonproliferative type 2 idiopathic macular telangiectasia.
    Charbel Issa P; Helb HM; Holz FG; Scholl HP;
    Am J Ophthalmol; 2008 Jan; 145(1):169-175. PubMed ID: 17981256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venovenous anastomosis in macular telangiectasia type 2: an unusual presentation.
    Oli A; Narayanan R
    BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32606110
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of visual acuity, metamorphopsia, and aniseikonia in patients with an idiopathic epiretinal membrane.
    Tanikawa A; Shimada Y; Horiguchi M
    Jpn J Ophthalmol; 2018 May; 62(3):280-285. PubMed ID: 29623543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SHORT-TERM FLUCTUATION OF MACULAR EDEMA IN A PATIENT DIAGNOSED EARLY WITH IDIOPATHIC MACULAR TELANGIECTASIA TYPE 1: FOLLOW-UP WITH SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY.
    Tsaousis KT; Empeslidis T
    Retin Cases Brief Rep; 2016; 10(3):263-6. PubMed ID: 26584327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.